Consideration of Pannexin 1 channels in COVID-19 pathology and treatment-Reference-Cited by-同舟云学术

Consideration of Pannexin 1 channels in COVID-19 pathology and treatment

Published:2020-07-01 Issue:1 Volume:319 Page:L121-L125
ISSN:1040-0605
Container-title:American Journal of Physiology-Lung Cellular and Molecular Physiology
language:en
Short-container-title:American Journal of Physiology-Lung Cellular and Molecular Physiology

Author:

Swayne Leigh Anne¹^ORCID,Johnstone Scott R.²³^ORCID,Ng Chen Seng⁴⁵,Sanchez-Arias Juan C.¹,Good Miranda E.⁶,Penuela Silvia⁷,Lohman Alexander W.⁸⁹,Wolpe Abigail G.¹⁰¹¹,Laubach Victor E.¹²¹³^ORCID,Koval Michael¹⁴^ORCID,Isakson Brant E.¹⁰¹³^ORCID

Affiliation:

1. Division of Medical Sciences, University of Victoria, Victoria, British Columbia, Canada

2. Fralin Biomedical Research Institute at Virginia Tech Carilion Center for Heart and Reparative Medicine Research, Virginia Tech, Roanoke, Virginia

3. Department of Biological Sciences, Virginia Tech, Roanoke, Virginia

4. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

5. Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada

6. Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts

7. Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, Canada

8. Department of Cell Biology and Anatomy, University of Calgary, Calgary, Alberta, Canada

9. Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

10. Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, Virginia

11. Department of Cell Biology, University of Virginia School of Medicine, Charlottesville, Virginia

12. Department of Surgery, University of Virginia School of Medicine, Charlottesville, Virginia

13. Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, Virginia

14. Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University School of Medicine, Atlanta, Georgia

Funder

Gouvernement du Canada | Canadian Institutes of Health Research

Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada

HHS | NIH | National Heart, Lung, and Blood Institute

Publisher

American Physiological Society

Subject

Cell Biology,Physiology (medical),Pulmonary and Respiratory Medicine,Physiology

Link

https://journals.physiology.org/doi/pdf/10.1152/ajplung.00146.2020

Reference67 articles.

1. Remdesivir as a possible therapeutic option for the COVID-19

2. Remdesivir for the Treatment of Covid-19 — Final Report

3. Probenecid Blocks Human P2X7 Receptor-Induced Dye Uptake via a Pannexin-1 Independent Mechanism

4. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series

5. A molecular signature in the pannexin1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Probenecid Inhibits Influenza A(H5N1) and A(H7N9) Viruses In Vitro and in Mice;Viruses;2024-01-19

2. Overlap in synaptic neurological condition susceptibility pathways and the neural pannexin 1 interactome revealed by bioinformatics analyses;Channels;2023-10-08

3. Determination of structural features that underpin the pannexin1 channel inhibitory activity of the peptide 10Panx1;Bioorganic Chemistry;2023-09

4. Probenecid ameliorates testosterone‐induced benign prostatic hyperplasia: Implications of PGE‐2 on ADAM‐17/EGFR/ERK1/2 signaling cascade;Journal of Biochemical and Molecular Toxicology;2023-06-23

5. SARS-CoV-2 E and 3a Proteins Are Inducers of Pannexin Currents;Cells;2023-05-25